EGM
TVTX icon

Engineers Gate Manager’s Travere Therapeutics TVTX Stock Holding History

Engineers Gate Manager’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.56M Buy
254,401
+117,793
+86% +$3.52M 0.09% 252
2025
Q4 		$5.22M Buy
136,608
+96,918
+244% +$3.15M 0.06% 329
2025
Q3 		$949K Sell
39,690
-71,117
-64% -$1.34M 0.01% 1181
2025
Q2 		$1.64M Buy
110,807
+21,023
+23% +$348K 0.02% 844
2025
Q1 		$1.61M Buy
+89,784
New +$1.82M 0.03% 801
2024
Q4 		– Sell
-62,245
Closed -$871K – 2585
2024
Q3 		$871K Buy
62,245
+20,485
+49% +$213K 0.02% 1087
2024
Q2 		$343K Buy
+41,760
New +$281K 0.01% 1392
2023
Q4 		– Sell
-108,375
Closed -$969K – 2274
2023
Q3 		$969K Buy
108,375
+48,485
+81% +$684K 0.04% 724
2023
Q2 		$920K Buy
59,890
+36,618
+157% +$666K 0.03% 738
2023
Q1 		$523K Buy
+23,272
New +$495K 0.02% 955
2022
Q4 		– Sell
-17,762
Closed -$438K – 2047
2022
Q3 		$438K Buy
+17,762
New +$459K 0.03% 898
2022
Q2 		– Sell
-16,331
Closed -$421K – 2272
2022
Q1 		$421K Sell
16,331
-7,469
-31% -$198K 0.02% 1163
2021
Q4 		$739K Buy
23,800
+7,646
+47% +$215K 0.03% 784
2021
Q3 		$392K Buy
+16,154
New +$297K 0.02% 1034
2020
Q4 		– Sell
-13,420
Closed -$248K – 1994
2020
Q3 		$248K Buy
+13,420
New +$261K 0.01% 1341
2020
Q2 		– Sell
-10,860
Closed -$158K – 1980
2020
Q1 		$158K Sell
10,860
-1,591
-13% -$23.9K 0.01% 1324
2019
Q4 		$177K Buy
+12,451
New +$159K 0.01% 1493

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Engineers Gate Manager's TVTX Position: Q1 2026 in Review

Engineers Gate Manager increased its Travere Therapeutics (TVTX) stake by 86% in Q1 2026, buying an estimated $3.52M and bringing the position to 254,401 shares worth $7.56M. The position accounts for 0.09% of the portfolio, ranked #252.

Engineers Gate Manager first reported a position in TVTX in Q4 2019 and has held it in 17 quarters since. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

  • Engineers Gate Manager held 254,401 shares of Travere Therapeutics worth $7.56M as of Q1 2026.
  • Engineers Gate Manager bought 117,793 Travere Therapeutics shares in Q1 2026, an estimated $3.52M.
  • Travere Therapeutics made up 0.09% of Engineers Gate Manager's portfolio in Q1 2026, its #252 holding.
  • Engineers Gate Manager first reported a position in Travere Therapeutics in Q4 2019 and has held it in 17 quarters since.
  • 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.